chevron_leftBack
As of 14 June 2026, Tianjin Chase Sun Pharmaceutical Co.,Ltd has a market cap of $1.52B USD, ranking #8380 globally and #2157 in China.
It ranks #702 in the Healthcare sector, and #269 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.52BUSD
10.3B CNY
Enterprise Value
$1.39BUSD
9.4B CNY
Revenue (TTM)
$690.46MUSD
4.68B CNY
EBITDA (TTM)
$96.67MUSD
654.22M CNY
Net Income (TTM)
$3.52MUSD
23.88M CNY
EBITDA Margin
14%
Profit Margin
0.5%
PE Ratio
275.3
PS Ratio
2.2
PB Ratio
1.2
EV/EBITDA
14.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Wu Jun Lan
open_in_new
Employees
5,297
Founded
1996
Website
chasesun.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.3% | 0.6% | -1.4% | -6.5% | -9.5% | 3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300026
天津红日药业股份有限公司 Class A
ISIN: CNE100000GF1
Shares Out.:
Shares Outstanding:
2.739B1
Shares Float:
1.702B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3.42 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Tianjin Chase Sun Pharmaceutical Co.,Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
3K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
1K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
986%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
953%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
50K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
36K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
24K%
|
97.4
|
|
SIX: RO
|
$321.52B
21K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
19K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
18K%
218.9B CHF
|
20.5
|
chevron_leftBack